These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24565254)

  • 1. Destination therapy with left ventricular assist devices: for whom and when?
    Porepa LF; Starling RC
    Can J Cardiol; 2014 Mar; 30(3):296-303. PubMed ID: 24565254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
    Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
    J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
    Daneshmand MA; Rajagopal K; Lima B; Khorram N; Blue LJ; Lodge AJ; Hernandez AF; Rogers JG; Milano CA
    Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
    Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
    Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
    J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implant strategies change over time and impact outcomes: insights from the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Teuteberg JJ; Stewart GC; Jessup M; Kormos RL; Sun B; Frazier OH; Naftel DC; Stevenson LW
    JACC Heart Fail; 2013 Oct; 1(5):369-78. PubMed ID: 24621968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
    Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
    J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High early event rates in patients with questionable eligibility for advanced heart failure therapies: Results from the Medical Arm of Mechanically Assisted Circulatory Support (Medamacs) Registry.
    Ambardekar AV; Forde-McLean RC; Kittleson MM; Stewart GC; Palardy M; Thibodeau JT; DeVore AD; Mountis MM; Cadaret L; Teuteberg JJ; Pamboukian SV; Cantor RS; Lindenfeld J
    J Heart Lung Transplant; 2016 Jun; 35(6):722-30. PubMed ID: 26987599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional differences in use and outcomes of left ventricular assist devices: Insights from the Interagency Registry for Mechanically Assisted Circulatory Support Registry.
    Krim SR; Vivo RP; Campbell P; Estep JD; Fonarow GC; Naftel DC; Ventura HO
    J Heart Lung Transplant; 2015 Jul; 34(7):912-20. PubMed ID: 25824553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac extracorporeal life support: state of the art in 2007.
    Cooper DS; Jacobs JP; Moore L; Stock A; Gaynor JW; Chancy T; Parpard M; Griffin DA; Owens T; Checchia PA; Thiagarajan RR; Spray TL; Ravishankar C
    Cardiol Young; 2007 Sep; 17 Suppl 2():104-15. PubMed ID: 18039404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular device as destination therapy: are we there yet?
    Badiwala MV; Rao V
    Curr Opin Cardiol; 2009 Mar; 24(2):184-9. PubMed ID: 19532106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
    Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
    J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of pediatric patients supported by the HeartMate II left ventricular assist device in the United States.
    Cabrera AG; Sundareswaran KS; Samayoa AX; Jeewa A; McKenzie ED; Rossano JW; Farrar DJ; Frazier OH; Morales DL
    J Heart Lung Transplant; 2013 Nov; 32(11):1107-13. PubMed ID: 24002006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support.
    Petrucci RJ; Rogers JG; Blue L; Gallagher C; Russell SD; Dordunoo D; Jaski BE; Chillcott S; Sun B; Yanssens TL; Tatooles A; Koundakjian L; Farrar DJ; Slaughter MS
    J Heart Lung Transplant; 2012 Jan; 31(1):27-36. PubMed ID: 22153550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of pre-operative interleukin-6 levels with Interagency Registry for Mechanically Assisted Circulatory Support profiles and intensive care unit stay in left ventricular assist device patients.
    Caruso R; Verde A; Cabiati M; Milazzo F; Boroni C; Del Ry S; Parolini M; Vittori C; Paino R; Martinelli L; Giannessi D; Frigerio M; Parodi O
    J Heart Lung Transplant; 2012 Jun; 31(6):625-33. PubMed ID: 22386451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Destination therapy with left ventricular assist devices: patient selection and outcomes.
    Slaughter MS; Meyer AL; Birks EJ
    Curr Opin Cardiol; 2011 May; 26(3):232-6. PubMed ID: 21430527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.